¡ÒúÃÃà·Ò·Ø¡¢ìµé¹ÃèÒ§»ÃÐÊÒ¹¤§¨Ð¡ÅÒÂà»ç¹¨Ø´Ê¹ã¨à¾ÃÒÐÇèÒ¡ÒÃÃÑ¡ÉÒâÃŴŧ«Ç´à«ÕÂáË觾ÃÃÉÒ 2021 «Öè§ 19 µÒÁ Julie CÁѹÊÁͧ Harper, MD ·Õè¡ÅèÒÇÇèÒ§Ò¹ãªé¡ÒÃá¡éâäËÅÒÂÇÔ¸Õà¾×èͨѴ¡ÒáѺ´Ñ¡ÍҳѵÔÊÑ­­Ò³ËÃ×ÍäÁè¡ç·Õ·èÒáµèÅЪ¹Ô´ÃÇÁ¤ÇÒÁÇèÒ 1C ÍѹáËè§Ë¹´Õ§ÒÁáç¡ÅéÒáÅТºÇ¹¡ÒÃáË觶éǹ·Ñèǵ¡¢Íº³§Ò¹Ê§à¤ÃÒÐËìá¡è¤¹»èÇ 1D;

ÎÒÃìàáÁŧ»ÍÃìÃÈ.´éҹ˹ѧ¨Ò¡ÁËÒÇÔ·ÂÒÅÑÂÍÅÒºÒŧÁÒáËè§Ë¹àºÍÃìÁÔ§áÎÁàºÍÃìÁÔ§áÎÁºéÒ¹àÁ×ͧ͡ÃÒºÅÒáÅÐàÍç´áË觡ÃÃÁ¡ÒüÙé¡èÍ¡Óà¹Ô´´éÇ¡ѹ¼Ùé¹ÓÁ¹Øª»Ñ¨¨ØºÑ¹ American AcneáÅÐ Rosacea Society ä´éÁÒ͸ԺÒ¨ô»ÃÐ⪹ìÊÔ觢ͧ´éÇ¡ѹÊٵáÒôÓçáËè§Ë¹¾ÑǾѹ¡Ñº´Ñ¡¡ÒÃàÂÕÂÇÂÒÃèÒ§¼ÊÁ¼ÊÒ¹³¡ÒùÓÃÒ§ҹÊÔ觢ͧà¸Í 1 ³¸ØáԨ ODAC Dermatology, Aesthetic and Surgical Conference 2021 Pre-Conference Sneak Peek Inflammatory Diseases Virtual Symposium ã¹·Õè´Ç§à´×͹¸Ñ¹ÇÒ¤Á 1

à¸ÍäÁèàÍ×éÍà¿×éÍ¡ÒôÓçàªè¹»ÃСÒÃà´ÕÂÇâ´Â¡ÒÃáºè§»ÃÐàÀ·¤¹»èÇ·Õèà»ç¹âäâëÒàÊÕÂËÅÑ¡ÕµÒÁª¹Ô´ (erythematotelangiectatic, papulopustular, phymatous ´éÇ¡ѹ ocular) ´éÇÂà˵طÕè·Õ·èÒÍÒ¨¨ÐºÕé«é͹¡Ñ¹à¹×èͧ¨Ò¡¤¹»èǤè͹¢éÒ§ÍÂÙèã¹¢èÒÂÁÒ¡¡ÇèÒàÍç´»ÃÐàÀ·¾Ç¡à¢Ò¨Ö觨Óà»ç¹µéͧãªé¡ÃÃÁÇÔ¸Õʶҹ·Õè·ÑèǶ֧à¨ÃÔ­à¾×èÍ·Õè¨ÐÃÑ¡ÉÒ·èÒ·Ò§ÊÃþÊÔè§à¢Ò·Ñé§ËÅÒÂä´éÁÒÍÂèÒ§ÁÕ»ÃÐÊÔ·¸ÔÀÒ¾¤Ø³àʹÍà¾ÔèÁ¾Ù¹

¡ÅÂØ·¸ìà˵شéÇ¡ÒúӺѴÃèÇÁ¡Ñ¹

¨´à¾ÔèÁ»ÃÐÊÔ·¸ÔÀÒ¾¡ÒúÃÃà·Ò·Ø¡¢ìµé¹ÃèÒ§¼ÊÁ¼ÊÒ¹ Harper ¡ÅèÒÇÇèÒ¼Ù黯Ժѵԧҹ¹èÒáºè§»ÃÐàÀ·¢Í§¤¹à¨çºÊС´Ã͵ÒÁ¤ÇÒÁà¨çº»èÇÂáÅÐÊÑ­­Ò³ÊÔ觢ͧ rosacea ÁÒ¡¡ÇèÒ»ÃÐàÀ·à¨éÒàÍç§á¹Ð¹ÓµÑǨèÒ»¡»éͧÍÔÃÔÂÒº¶áËè§Ë¹àËç¹ä´é·Ñé§ÊÔé¹

1C ÃͤÇÒÁà¨çºä¢é´éÇ¡ѹ·èÒ·Ò§áÊ´§áË觼ԴἡËéÒÁ¨Ñ¡¨Óµéͧãªé¡ÒÃÃÑ¡ÉÒÁÒ¡á¹Ç·Ò§ ä´éá¡è 1D;ÎÒÃìàáÁŧ»ÍÃìâ¹éµà¾Å§

1. ÍàÁÃÔ¡ÒÍÂ. (FDA) - ¢Ñ鹵͹ÃÑ¡ÉÒʶҹ·Õèä´éÃѺ§Ò¹µé͹ÃѺà¾ÃÒÐÇèÒ¡ÒôÓç·Õ·èÒàÅ×Í´¤Ñè§ÍÑ¡àʺÊÔ觢ͧ rosacea, papules ´éÇ¡ѹ pustules ËÁÒÂÃÇÁ ivermectin (IVM), metronidazole, azelaic acid ¡Ñº sodium sulfacetamide ´éÇ¡ѹÁÒȡѺ¡ÒûŴ»ÅèÍ doxycycline
2. Alpha agonist brimonidine (BR) ¡Ñº oxymetazolinZe «Öè§ÃкØÇÒ§à¹×èͧ´éÇ·èÒ·Õ¼´à¡´º¹ºÒ¹Ë¹éÒµÒËÃ×ÍäÁè¡ç¼´ÊÂØÁ¾Ãʶҹ·Õèà»ç¹¾×é¹»Äɮҧ¤ì
3. ¡ÒôÓçà¾ÃÒÐÇèÒãªéà¤Ã×èͧÁ×Íàªè¹áʧàÅà«ÍÃìÊÕÂéÍÁÀÒ¾ÃèÒ§¾ÑÅ«Ôè§ JTP »ÃСÒÂ俾ÑÅ«Ôè§¢é¹ (IPL) ËÃ×ÍÇèÒ¡ÒõѴ¿Ñ¹àªè¹¡Ñ¹¡ÃÐáÊä¿¿éÒ

Harper à¹é¹ÂéÓáËǨشËÁÒÂÁÔãªèà·èÒ¡ÒûÃѺ»ÃاºÒ§Êèǹ´Óç°Ò¹ÐÇÃóÐáËè§Ë¹ªÑ´à¨¹ªÑ´à¨¹ª¹Ô´¨ÓàÃÔ­¡ÒôÓçµé¹©ºÑº»ÃÐÊÁ»ÃÐÊÒ¹ÊÒÁÒöÅØé¹á¨¡¤¹»èÇÂáËè§Ë¹à»ç¹âä⵫ҫǹà«ÕÂÊÓàÃç¨ä´éá¨é¹¡ÃзÑ觡ÒÃÃÑ¡ÉÒ¾Ò§·Õ¼Ùéà´ÕÂǡѺ·ÇÕÃÐÂÐàÇÅÒ¡Òáâ·ÉãËéàµçÁ·Õ赡¢Íº·Ñ駷ÕèµÑ´·Í¹¸ØÃÐâäáºè§ÍÍ¡¡Ñº¼Ùé»èÇÂ

ÎÒÃìàáÁŧ»ÍÃìà¹é¹¡ÒÃËÒ¤ÇÒÁÃÙéµÔ´µÒÁËÅÑ¡°Ò¹Ê¶Ò¹·ÕèʹѺʹع¡ÒôÓçµé¹ÃèÒ§¼ÊÁ¼ÊÒ¹¡ÒÃàÃÕ¹ÃÙéáË觾ÃÃÉÒ 2550 ÀÒ¾ÃèÒ§ÊØèÁµÑÇÍÂèÒ§µé¹ÃèÒ§ double-blind áÅÐ placebo-controlled 2 «Ö觻¯ÔºÑµÔ¡ÒÃ㹵͹ 16 ÍÒ·ÔµÂì¾Ò¹¾ºáËǼÅÃÇÁÃÍÂá¼ÅÍÑ¡àʺŴŧ»ÃСÒÃÁչѻÃиҹËÅѧ¨Ò¡¼èÒ¹ä» 12 ÍÒ·ÔµÂìàªè¹¡Ñ¹§Ò¹ãªé¤×¹ doxycycline ·ÕèÁÕÊÔ·¸Ôì§Ò¹à»ÅÕè¹á»Å§³¨Ó¹Ç¹ÃÇÁ·ÕèµéÒ¹§Ò¹ÍÑ¡àʺáÅÐ metronidazole gel 1%¤¹à¨çººÒ§ÃÒÂáË觶×ÍÊÔ·¸Ôì¡ÒÃàÂÕÂÇÂÒÃÑ¡ÉÒÃÇÁËÑÇàʹÍáËÇ·èÒ´Õ¢Öé¹á¨é¹·ÕèÊØ´áËè§ÍÒ·ÔµÂìʶҹ·Õè 4 §Ò¹Å´Å§µÃ§¹Õé¼èÒ¹¾º¤ÇéҨôÍÒ·ÔµÂìʶҹ·Õè 12 ÁչѻÃиҹàÁ×èÍà»ÃÕºà·Õº¡Ñº´Ñ¡à¨Å metronidazole 1% ʶҹ·Õèãªé¡ÑºÂÒËÅÍ¡

㹪ѹÉÒ 2560 ¹Ñ¡¤é¹¤ÇéÒ¤ÇéÒµÃǨ¤ÇÒÁ»ÅÍ´ÀÑ´éÇ¡ѹÊÁÃö¹ÐÊÃþÊÔè§ÊÕ¤ÃÕÁ IVM 1% ੾ÒзÕè¡Ñº BR 0.33% ·Õè¡ÒÃàÃÕ¹ÃÙéÃèÒ§ÊØèÁáÅФǺ¤ØÁÍÕ¡´éÇÂÂÒ¹¾Ò˹Ðá»Å¹ÁÒ¡ÁÒÂ᡹¡ÅÒ§¤¹»èÇ»ÃСͺ´éÇÂâäÀÑÂä¢éà¨çº»èͧ«ÒàÊÕÂËÅÑ¡ÕÂã¹·ÕèÃдѺ»Ò¹¡ÅÒ§¶Ö§Ãعáçà¾ÃÒÐÇèÒÁÕµÅÍ´¼×è¹Ë¹éÒÊÑ鹡ÃШÒÂÃèÒ§¶ÒÇÃáÅлÃСͺ´éÇÂàÅ×Í´¤Ñè§ÍÑ¡àʺ¡ÑºµØèÁ˹ͧ¹éÓ

1C; §Ò¹ãªé¤×¹¤ÃÕÁ IVM ÃèÇÁ¡Ñº BR gel ºÍ¡ãËéàË繨ô¤ÇÒÁÊÒÁÒöáÅÐÊÇÑÊ´Õʶҹ·Õè´Õ§ÒÁ«Öè§ÃѺÃͧ¡Ãкǹ¡ÒÃáËè§Ë¹¶éǹ·ÑèÇà¹×èͧ´éǤÇÒÁà¨çº»èÇÂʶҹ·Õè«Ñº«é͹¹Õé¡ÒÃá¹Ð¹Ó BR ã¹·Õèªèǧµé¹¾ÃéÍÁ¡ÑºÊٵçҹÊÍ´Êèͧ´ÙáżÔÇ·Ø¡Çѹ·Õèà¨ÃÔ­¤§¨ÐÅØé¹Ãպ͸ԤÁã¹·Õè¡ÒÃÃÑ¡ÉÒà¾ÃÒÐäÁèà»ç¹à˵ØãËé¤ÇÒÁ·¹Å´Å§ 1D;¤¹à¢Õ¹àÃÕ¹ÃÙé¨Ñºã¨¤ÇÒÁ 3

ÍÂèÒ§äáçµÒÁ§Ò¹Å´àÅ×Í´¤Ñ觡ѺµØèÁ˹ͧ¹éӡѺ¡ÒõѴ·Í¹àÁç´àÅ×Í´á´§äÁèãªèàªè¹¹Ñ鹡ÒôÓçʶҹ·ÕèÁÒ¡¢Öé¹µÔ´ÊÍÂËé͵ÒÁ¢éÍÁÙÅÊÃþÊÔè§ Harper1C; ¡Òáӷմ¨Ø´ËÁÒ»ÅÒ·ҧ§Ò¹ÍÑ¡àʺáËè§àÅ×Í´¤Ñ觴éÇ¡ѹâÍ觹éÓ˹ͧ¹éÓäÁèä´éà»ç¹¼ÅãËé¼×è¹à¹×éÍÍè͹ʶҹ·ÕèªÑé¹¾ÃТ¹Í§¹éÍÂŧ "à¸Í¡ÅèÒÇ" ¡ÒÃàÂÕÂÇÂҵ鹩ºÑº»ÃÐÊÁ»ÃÐÊÒ¹ÊÁÃö¨Ó¡Ñ´¤ÇÒÁÁØè§ËÁÒÂÊͧÍѹµÃ§¹Õé¤ÇéÒ 1D;

à¾ÃÒÐÇèÒâäµÒá´§à¸ÍÂéÓ¡ÒÃÊÍ´Êèͧ´ÙáŽҼ¹Ñ§´éÇ¡ѹá¹Ð¹ÓµÑÇÁҵðҹ¨Ò¡¡ÒÃÊÑÁÁ¹ÒàªÔ§»¯ÔºÑµÔ¡ÒùҹһÃÐà·Èà赯 Meibomian Gland Dysfunction (MGD) «Öè§á¹Ð¹ÓµÑÇᨡãªé¡ÒùҺÍÕ¡´éǤÇÒÁͺÍØ蹡ÒùǴ¼¹Ñ§¹Ñ¹ÒÁ¾Ø¨ÍÁ»ÅÍÁÂÒ·ÒÍÐÊÔâ·ÃÈѾ·ìÅÒÊÔ¹¹éÓÁѹËÅèÍÅ×è¹à©¾ÒзÕè·ÓãËéÇÃóйÇÅËÃ×ÍäÁè¡çÊà»ÃÂìäÅ⻷ҡѺ´çÍ¡ÀÒÉÒ«Õ䫤ÅԹ㹷Õèªèͧ»Ò¡ËÅÑ¡¹ÕéÍÕ¡·Ñé§ËÁÒÂÃÇÁ¡ÒÃãªé cyclosporine ੾ÒзÕè´éÇ¡ѹÊàµÕÂÃÍ´ì੾ÒзÕèã¹¢³Ð·Õèá¡ÐÃͤÇÒÁ´Ñ¹´Ç§µÒ

1C; ¡ÒÃÍÑ¡àʺËÁ´´éÇ¡ѹà»ÅèÒàËÁ×͹¡Ñ¹ 1D;à¨éÒàÍ秹Թ·ÒÁѹÊÁͧà¸Íà¹é¹ÃÒ§ҹ·Ñ駻ǧ·èÒ·Õèà»ç¹Êèǹ˹Ö觢ͧ rosacea ÊÔ觢ͧ¼Ùé»èÇ´éÇ¡ѹÃÑ¡ÉÒ´éÇÂÇÔ¸Õ¡ÒÃËÅÒ§èÒÁµÃ§¹Õé

¡ÒûÃÐà¨Ô´»ÃÐà¨éÍ»ÃСÒÈ:

´çÍ¡àµÍÃìHarperhas ·ÙÅ¡ÒÃäÁèÁÔ´ªÔ´¢èÒÇáËè§Ë¹¢éͧáÇСѺ Almirall, Cassiopeia, Cutera, EPI, Galderma ´éÇ¡ѹ L19; Oreal

ÍéÒ§ÍÔ§: àÅà«ÍÃì ÃÍÂÊÔÇ

1.ÎÒÃìàáÁŧ»ÍÃìà¨ÀÒÉÒ«Õ.¡ÒôÓçâäÀÑÂä¢éà¨çºâµÅ´Å§«Ç´à«ÕÂáËè§»Õ 2564 ¹ÓàʹͷÕè: 2021 ODAC Pre-Conference Sneak Peek Inflammatory Diseases Virtual Symposium;3 ¸Ñ¹ÇÒ¤Á 2020

2.¿ÒÇàÅÍÃìà¨àÍ¿ÁѹÊÁͧ¨Ó¹Ç¹¢Í§ÂÒàʾµÔ´ doxycycline äÁèàËç¹´éÇ¡ÒÃÍÑ¡àʺ (doxycycline 40 Á¡., ᤻«ÙŤǺ¤ØÁ¡ÒûŴ»ÅèÍ usp monohydrate) áÅÐ metronidazole topical gel 1% ³¡ÒôÓç rosaceaÂÒàʾµÔ´ ਠDermatol. 2007;6(6):641-645.

3.Gold LS, Papp K, Lynde C ¡ÑºÍ×è¹ æ¡ÒôÓç rosacea àªè¹¡Ñ¹¡ÒÃãªéÊÕ¤ÃÕÁ ivermectin 1% ¡Ñºà¨Å brimonidine 0.33% ÃÇÁËÑÇ: ¡ÒÃàÃÕ¹á»Å¹ÊØèÁµÑÇÍÂèÒ§¤Çº¤ØÁ¾ÃéÍÁ´éǾÒ˹ÐÂÒàʾµÔ´ ÁѧÊÇÔÃÑµÔ Dermatol